Aspen Aerogels (NYSE:ASPN) Shares Pass Above Fifty Day Moving Average – Here’s What Happened

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.24 and traded as high as $3.60. Aspen Aerogels shares last traded at $3.5450, with a volume of 834,851 shares changing hands.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Barclays decreased their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Hold” and an average price target of $12.67.

Aspen Aerogels Stock Performance

The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The company has a market capitalization of $292.99 million, a PE ratio of -0.95 and a beta of 2.94. The stock has a 50-day simple moving average of $3.24 and a 200 day simple moving average of $5.67.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The firm had revenue of $73.02 million for the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.The company’s quarterly revenue was down 37.8% compared to the same quarter last year. During the same period last year, the firm earned ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the firm’s stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the transaction, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This trade represents a 10.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Aspen Aerogels by 0.5% in the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock worth $31,392,000 after acquiring an additional 22,686 shares during the last quarter. Gagnon Securities LLC purchased a new stake in Aspen Aerogels during the 2nd quarter worth about $11,243,000. Federated Hermes Inc. acquired a new position in Aspen Aerogels in the 2nd quarter valued at about $10,459,000. Geode Capital Management LLC lifted its holdings in Aspen Aerogels by 4.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,582,742 shares of the construction company’s stock valued at $9,371,000 after purchasing an additional 66,967 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Aspen Aerogels by 59.6% in the 3rd quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock valued at $10,075,000 after purchasing an additional 540,772 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.